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A set of isoprenylated proteins has been detected in rapidly proliferating, suspension-grown murine lymphoma cells. Our 
evidence indicates hat all of these isoprenylated proteins are phosphorylated. Subsequent to a 24 h incubation with 
mevinolin to deplete the intracellular mevalonate (MVA) level, cells were incubated with PHIMVA and/or 3ZPi and both 
total cell and subcellular f action proteins were resolved via 1- and 2-D gel electrophoresis, then assessed via subsequent 
autoradiography. The phospho-isoprenylated proteins comprise a set spanning a molecular mass range of 21-69 kDa 
and all dispay acidic PI. MVA-derivatized proteins of 21-24 kDa, which consist of multiple isoforms, are present in both 
cytosolic and nuclear fractions. Larger phospho-isoprenylated protein species (4469 kDa) are specifically localized with- 
in the nucleus, where applicable extraction protocols indicate that they are part of or closely affiliated with the nuclear 
matrix-intermediate filament (NM-IF) components. The localization of the 69 kDa prenylated species within the NM-IF 
fraction, together with evidence of its phosphorylation, supports recent indications that this protein is the nuclear matrix 
component lamin B. 
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1. INTRODUCTION 
A direct correlation has been shown between the 
rate of cell replication and that of carbon flux 
through the cholesterogenesis pathway [l-4]. The 
normal S-phase burst of DNA synthesis is 
specifically prevented upon inhibition, during mid- 
to-late G1, of the rate controlling enzyme of 
cholesterogenesis, 3-hydroxy-3-methylglutaryl 
CoA reductase (HMGR) with either oxygenated 
sterols [5] or with competitive inhibitors of the en- 
zyme, compactin and mevinolin [6-121. By in- 
hibiting HMGR, cells become depleted of 
mevalonate. Many observations collectively in- 
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dicate that mevalonate deprivation starves cells of 
additional factors apart from those isoprenoid in- 
termediates that are employed in cholesterol syn- 
thesis and the more common prenyl metabolites 
that arise from branches off the main cholestero- 
genie pathway. Thus, while mevalonate serves not 
only as direct precursor for the synthesis of sterol 
and other well-known isoprenoid metabolites (e.g., 
dolichol, the prenyl side chain of ubiquinone, etc.), 
it has been established that, in addition, it is 
employed as a source from which a new class of 
terpenylated proteins is generated [13-l 61. 
Soon after the discovery and preliminary 
characterization of these mevalonate-derived, iso- 
prenylated proteins [ 131, Sinensky and Loge1 [ 141 
convincingly demonstrated their unique impor- 
tance with regard to DNA replication relative to 
other prenyl intermediates generated by the sterol 
synthesis pathway, such as isopentenyl t-RNA. 
Subsequently, Maltese and Sheridan [ 171 reported 
detecting a set of similarly derivatized proteins in a 
variety of transformed as well as normal cell lines 
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in culture. They showed such proteins to have 
molecular masses ranging from about 17 to 
66 kDa, and that they are differentially distributed 
within subcellular fractions, including the nucleus. 
Recently, Wolda and Glomset [18] reported that 
one of these isoprenylated proteins, affiliated with 
the nuclear matrix, is immunologically definable as 
lamin B. 
We provide here further characterization of 
mevalonate-derived, isoprenylated proteins 
detected in a murine lymphoma cell line grown in 
suspension, and show that the larger of these pro- 
tein species are preferentially localized within the 
nucleus where they appear to be associated pre- 
dominantly with nuclear matrix material, confirm- 
ing recent findings [18,19]. Furthermore, we find 
that every prenylated protein within this set of 
MVA-derivatized proteins is phosphorylated. 
2. MATERIALS AND METHODS 
2.1. Reagents 
(RS) [5-‘HlMevalonolactone, [‘*P]orthophosphate, and 
EN3HANCE were from DuPont-New England Nuclear 
(Boston, MA). Mevinolin was a kind gift from Dr A. Alberts 
(Merck & Co.) and was converted to the Na+ salt before use as 
described in [19]. Nonidet P-40, leupeptin, pepstatin, DNase I, 
and RNase A were from Sigma (St. Louis, MO). All electro- 
phoresis reagents were from RioRad (Rockville Centre, NY). 
Fetal bovine serum (FBS), RPM1 1640, penicillin/streptomycin 
and glutamine were from Gibco (Grand Island, NY). All other 
reagents and chemicals were from standard commercial sup- 
pliers and were used without further treatment. 
2.2. Cells 
The pre-B murine lymphoma cell line, 702/3, was grown in 
suspension in RPM1 1640 supplemented with 10% FBS, 2 mM 
glutamine, 5 gM 2-mercaptoethanol, 0.05% pluronic acid and 
50 U/ml each of penicillin and streptomycin (complete 
medium). Viability was determined via trypan blue dye exclu- 
sion cell counts in a hemocytometer, and all studies were in- 
itiated with cultures displaying viabilities >95%. 
2.3. Incubations with fH]mevalonate and 32P 
Exponentially growing 7OZ/3 cultures (2.5 x 10s cells/ml) 
were treated for 24 h with 30pM mevinolin in complete 
medium. Viability after this 24 h incubation period still exceed- 
ed 86%. The mevinolin-treated cells were harvested by low- 
speed centrifugation and resuspended at 10’ cell/ml in a labell- 
ing cocktail containing 200 &i/ml [3H]mevalonolactone in 
complete culture medium that contained 30 pM mevinolin. Cells 
were incubated at 37’C for 3 h in this radioactive mixture and 
harvested by low-speed centrifugation. The pellet was washed 
twice with ice-cold phosphate-buffered saline (PBS) and re- 
suspended in 10 mM Tris, pH 7.4, 100 mM KCl, 2 mM MgClz, 
30 mM NaF, 1 mM dithiothreitol (DTT), 5 pg/ml each of 
leupeptin and pepstatin, and 50 pg/ml of DNase I and RNase A. 
After homogenizing the cells (Dounce), the homogenate was 
warmed to 27°C to permit nuclease activity for 15 min. Total 
cellular protein was precipitated with 5 vols of cold acetone, 
then dried under a stream of Nz, and resuspended in the ap- 
propriate gel buffer for electrophoresis. For in vivo phos- 
phorylation with [32P]orthophosphate, mevinolin-treated cells 
were preincubated for 1 h in phosphate-free RMPI medium. 
Thereafter, cells were labelled for 3 h with 400 &i/ml “Pi in 
mevinolin-containing, phosphate-free medium, supplemented 
with either 4OO&i/ml of (RS) [5-3H]MVA or 100pM cold 
mevalonolactone. After the labelling period, cells were process- 
ed as above, except that all buffers contained phosphatase in- 
hibitors (30 PM NaF, 440 pM EDTA). 
2.4. Gel electrophoresis 
For non-equilibrium pH, 2-D gel electrophoresis (NEPHGE) 
samples were dissolved in freshly prepared 9.5 M urea, 2% 
Nonidet P-40, 5% 2-mercaptoethanol, 2% ampholyte mixture 
(pH range 3-lo), and both electrophoretic dimensions were run 
sequentially as described [20]. The pH profile in the first (iso- 
electric focusing) dimension was determined according to [21], 
and low molecular mass protein markers were co-electro- 
phoresed in the second (12.5% SDS-PAGE) dimension. Gels 
were stained with Coomassie blue R-250, partially destained, 
impregnated with EN3HANCE, dried, and exposed to Kodak 
X-Omat AR film at - 80°C. 1-D SDS-PAGE was performed ac- 
cording to Laemmli [22]. 
2.5. Cell fractionation 
Cells (109) were incubated for 24 h in the presence of 
mevinolin, then radiolabelled with [“Hlmevalonolactone for 3 h 
and harvested as described above. The pellet was resuspended in 
0.25 M sucrose, 4 mM MgClz, 10 mM Tris, pH 7.4, and 
5 pg/ml each of leupeptin and pepstatin, and homogenized on 
ice. Subcellular fractionation was performed via two different 
procedures. The first was according to Boland and Tweto [23], 
and nuclear matrix was retrieved as recently described [24]. An 
alternate procedure was also employed. After Dounce 
homogenization in PBS on ice and centrifugation (650 x g, 
5 min, 4”C), the supernatant proteins were precipitated with 
cold acetone, while the nuclear pellet was resuspended in 5% 
(w/v) Na-citrate. This suspension was overlayered onto a 30% 
sucrose cushion and centrifuged (2000 x g, 5 min, 4OC). After 
washing the nuclear pellet with 50 mM NaCl/lO mM Na-acetate 
buffer, pH 5, it was resuspended in 0.5 ml of this buffer. For 
both cell fractionation procedures, each fraction was subjected 
to acetone precipitation and resuspended to the same protein 
concentration in SDS-gel electrophoresis sample buffer, then 
resolved on 12.5% gels. Autoradiograms of the gels were 
prepared after impregnation with EN3HANCE and exposure to 
X-OMAT film for 1 month at - 80°C. Nuclear fractionation of 
mevinolin-treated, [3H]MVA-labelled 7OZ/3 cells was perform- 
ed as described for B lymphocytes [24]. 
3. RESULTS AND DISCUSSION 
3.1. Detection of rnevalonate-derived, phospho- 
isoprenylated proteins 
The ability to detect proteins derivatized with 
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Table 1 
Effect of mevinolin on sterol synthesis and murine lymphoma cell growth 
March 1989 
Control Plus mevinolin 
Sterol 
synthesisa 
(3)’ [U-‘Qacetate 94212 + 9790 dpm 3806 + 389 dpm 
(100%) (4070) 
(3) [2-“Ylpyruvate 1018 + 20 dpm 25 + 5 dpm 
(lOOcrl0) (2.4%) 
Cell growth 
parametersb 
(22) Inhibition in total 
cell number (070) 
(22) Viability (post 24 h) 
_ 
>95% 
43.5 t 2.1 
> 86% 
(12) ‘H-TdR incorp. 
into TCA-precip. 
counts 
41542 + 1655 dpm 
(100%) 
10620 f 738 dpm 
(25.6%) 
(22) Doubling time (h) 12.07 + 0.41 22.13 + 1.50 
a 14C incorporation into digitonin-precipitable sterol after a 3 h incubation in complete medium with 5 &i/ml acetate or 7.5 &i/ml 
pyruvate under incubation conditions given 
b DNA synthesis assessed as TCA-precipitable counts after a 24 h incubation under conditions given, via a 30 min pulse with 
[CHS-‘H]TdR (1 pW1.25 x 10’ cells) 
’ Number of individual experiments are reported in parentheses next to the condition assessed 
mevalonate metabolites requires prior depletion of 
the intracellular mevalonate pool in order to follow 
the fate of added [‘Hlmevalonate. Incubation of 
cell cultures with 30 PM mevinolin for 24 h inhibits 
HMGR almost completely [ 13,181. Under these 
conditions, incorporation of [U-14C]acetate and 
[2-14C]pyruvate into digitonin-precipitable sterols 
is reduced by 96% and 98%, respectively, com- 
pared to untreated cultures. In addition, cell 
growth is inhibited by -44070, with a concomitant 
increase in the doubling time from 12 h to >20 h 
(table 1). After mevinolin treatment, 7OZ/3 cells 
are arrested in late Gr or at the Gi/S boundary. 
This was verified by comparing the kinetics of 
[3H]TdR incorporation into trichloroacetic acid- 
precipitable counts for both mevinolin-treated cells 
that were re-fed MVA, and double thymidine 
block-synchronized cultures; the kinetic patterns 
and the total cpm incorporated are indistinguish- 
able (fig. 1). 
Subsequent o mevinolin inhibition, cells were 
pulse labelled with [3H]MVA and their proteins 
were then extracted and resolved via 2-D 
NEPHGE. Fig.2 indicates that such 3H-labelled 
proteins constitute a set which spans a molecular 
mass range of 21 to about 69 kDa, and all the 
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Fig.1. Kinetics of [‘H]TdR incorporation. 7OZ/3 cells, in- 
cubated according to Rao and Coleman [25], were treated either 
with 30 FM mevinolin for 24 h (0) or synchronized by double 
thymidine blockade (0). At different times after release from 
the cell cycle block by resuspension in fresh complete medium, 
1.25 x lo5 viable cells/O.25 ml were pulsed with 1 pCi of 
[CH,-3H]TdR for 30 min. Cells were harvested by 10% TCA 
precipitation onto glass fiber filters, and the filters were washed, 
dried and counted via liquid scintillation. Each point represents 
the mean of 12 determinations. 
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Fig.2. 2-D NEPHGE fluorographic X-ray pattern of [‘HIMVA 
incorporation into total proteins of mevinolin-treated lym- 
phoma cells. Cells were treated for 24 h with 30 PM mevinolin, 
then incubated for an additional 3 h in the same mevinolin- 
containing complete medium plus 200,uWml of RS [5-‘HI- 
mevalonolactone. Samples were prepared and 2-D gels were run 
and exposed to X-ray film as described in section 2. 
members of this set exhibit acidic pZ values. 
Another modified protein (56 kDa), due to its very 
acidic pZ, did not resolve in the 2-D gel system, but 
is evident via 1-D SDS-PAGE (see below, fig.4). 
The existence of two distinct pZ families of iso- 
forms with molecular masses of about 21 and 
24 kDa led to the suspicion that for both species, 
varying degrees of phosphorylation might have oc- 
curred. Mevalonate-depleted cells were therefore 
double labelled by incubation with both [3H]- 
mevalonate together with [32P]orthophosphate for 
3 h, and the isolated proteins resolved via 2-D 
NEPHGE. The difference in &particle emission 
energies and penetration levels of 3H versus ‘*P 
over a 48 h exposure permitted the specific detec- 
tion of the 32P pattern by blocking the X-ray film 
from 3H emission with a sheet of paper interposed 
between gel and film (complete ‘H blockage was 
obtained via this procedure). Tritium and 32P 
distribution were evaluated by excising individual 
Coomassie-stained spots from the dried gel, and 
upon digestion in Protosol (DuPont-NEN), assess- 
ing radioactivity by liquid scintillation. Superim- 
position of the 3H pattern of fig.2 onto that of the 
32P ARG pattern of fig.3 (A or B) clearly indicates 
that all MVA-derivatized proteins are also phos- 
phorylated, although to different extents. Fig.3A 
shows those spots containing both 32P and ‘H (ar- 
Fig.3. 2-D NEPHGE autoradiogram of “P incorporation into 
mevinolin-treated lymphoma cell proteins. Labelling incuba- 
tions and sample preparation were identical with those for fig.2, 
except that all buffers were supplemented with phosphatase in- 
hibitors (30 PM NaF and 440 pM EDTA), and labelling incuba- 
tions for (A) were double labelled, containing RS [S3H]MVA 
(400 &i/ml) as well as 400 &i/ml [‘*P]PO:-, whereas for (B) 
they contained 100,uM cold MVA together with 4OO&i/ml 
[32P]PO:- in phosphate-free RPM1 (otherwise complete) 
medium. 2-D NEPHGE slabs were Coomassie-stained, estain- 
ed, dried, and exposed to Kodak X-OMAT AR film for 2 days 
at - 80°C (without EN3HANCE) with a heavy paper sheet in- 
terposed between gel and film. Arrows in B indicate those ‘*P- 
labelled proteins that, via scintillation counting, also were found 
to contain the [3H]MVA in A. 
rows). A control experiment (fig.3B) in which cells 
were singly labelled with 32P (plus cold mevalonate) 
demonstrates that the 32P ARG pattern is identical 
to that obtained when the incubation contained 
both 3H and 32P labels. 
Fig.3A and B provides strong evidence for the 
phosphorylation of all the prenylated proteins 
detected. It should be recognized that the current 
lack of antibodies against these species rendered 
the double-labelling experiments the only pro- 
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cedure by which the entire set could be une- 
quivocally identified. 
3.2. Subcellular distribution of the MVA- 
derivatized proteins 
Regardless of which of the two cell fractionation 
procedures was employed, MVA-derivatized pro- 
teins of high molecular mass (44-69 kDa) were 
always localized within the nuclear fraction (fig.4, 
lane N), whereas the two families of low molecular 
mass isoforms (21-24 kDa) appeared to be concen- 
trated in the cytosol (fig.4, lane S). None of these 
prenylated proteins was found within the 
mitochondrial, microsomal or plasma membrane 
fractions (fig.4, lanes D, M and P, respectively). 
Further nuclear subfractionation was performed 
in order to generate nuclear matrix-intermediate 
filament (MN-IF) and chromatin fractions. It was 
found that the 69, 47 and 44 kDa isoprenylated 
proteins are affiliated with the NM-IF scaffold of 
the 7OZ/3 cells. Thus, upon nuclease treatment, 
these MVA-derivatized proteins resisted extraction 
with Triton X-100 in a low ionic strength buffer 
(chromatin fraction), and remained insoluble in 
a 
A 
N D S M 
this buffer even when supplemented with 2 N NaCl 
(NM-IF fraction). In contrast, the small amount of 
residual 21-24 kDa derivatized proteins present 
within the nucleus was easily extracted in the 
chromatin fraction. FigSA shows the distribution 
among different cell fractions of [3H]MVA-derived 
proteins resolved via 10% SDS-PAGE. The dif- 
ferential distribution of the large and small 
derivatized proteins in the NM-IF and chromatin 
fractions is clearly discernable. The NEPHGE 
autoradiogram of NM-IF proteins (fig.SB) con- 
firms the absence of low molecular mass iso- 
prenylated proteins in this fraction; only the 69, 47 
and 44 kDa proteins are evident. 
Recently, Wolda and Glomset [ 181 identified the 
69 kDa prenylated protein as lamin B. This major 
laminar component (and the only lamin present in 
lymphoid cells [26]), is subject to a variety of post- 
translational modifications [27-301. This report in- 
dicates for the first time that every one of the 
prenylated proteins in this set of cholestero- 
genitally-linked, MVA-derivatized proteins, is 
phosphorylated, including the prenyl-modified 
lamin B. The known posttranslational modifica- 
G P N S 
Fig.4. Cell fractionation of mevinolin-treated, [‘HIMVA-labelled cells. For A, cell homogenates obtained via the methods for fig.2 were 
fractionated according to [24], and proteins from the following fractions were analyuzed via 12.5% SDS-PAGE and subsequent 
fluorography. Lanes: N, nuclei; D, mitochondria; S, cytosol; M, microsomes; P and G, plasma membrane and the 30% sucrose gradient 
layer, respectively. For B, cells were homogenized in 5% citric acid, and the nuclear fraction separated and further purified via cen- 
trifugation as in section 2. Nuclear (N) and cytoplasmic (S) proteins were assessed as in A. A nuclear isoprenylated protein of 56 kDa, 
and an isoelectric point less than pH 4.5, is resolved via these 1-D SDS gels. 
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Fig.5. Nuclear fractionation of mevinolin-treated, [‘HIMVA-labelled cells. Matrix and chromatin fractions were obtained according to 
[24], and proteins from each fraction were extracted via acetone precipitation then assessed by 10% SDS-PAGE or 2-D NEPHGE. For 
A, the ‘H cpm profiles were derived from 10% SDS-PAGE slices of total cellular, total nuclear, nuclear matrix and chromatin fractions, 
as indicated. For B, the 2-D NEPHGE fluorogram of the [‘HIMVA-labelled, nuclear matrix-associated (IF) proteins is shown. 
tions of lamin B affords room for additional 
speculation, since its methylation and phos- 
phorylation have been shown to be cell cycle 
regulated; hypermethylation is manifest during in- 
terphase and a high degree of multiple site phos- 
phorylations occurs during mitosis [27-301. 
The predominant localization of this set of 
phospho-isoprenylated proteins within the nucleus 
prompts interesting questions concerning their 
roles during DNA synthesis. It is conceivable that 
the isoprenylation and phosphorylation serve as 
recognition signals for their translocation into the 
nucleus, thereby classifying these proteins among 
the ‘amphoteric’ species described by Burn [31]. It 
is also reasonable to propose that their covalent 
prenylation functions as a hydrophobic linker that 
helps both to anchor certain of them (e.g., lamin B) 
to the nuclear envelope as well as to particular 
chromatin domains in the nuclear matrix. The 
lamina itself provided not merely a substructure 
for nuclear envelope organization, but is also a ma- 
jor chromatin anchoring site during interphase 
[32]. Thus, the dependence of DNA replication on 
the synthesis of mevalonate, and thereby on the 
creation of this set of mevalonate-derived, 
phospho-isoprenylated proteins, may provide a 
clue regarding the interdependence of an active 
cholesterogenesis pathway and cell proliferation. 
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